Production (Stage)
Amphastar Pharmaceuticals, Inc.
AMPH
$25.26
-$0.27-1.06%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -8.44% | 15.98% | 16.58% | 63.34% | 66.04% |
| Total Depreciation and Amortization | 20.90% | 36.93% | 59.51% | 90.82% | 67.42% |
| Total Amortization of Deferred Charges | -65.35% | -47.08% | -3.46% | 260.89% | 2,465.33% |
| Total Other Non-Cash Items | -5.76% | -69.53% | 167.19% | 5.18% | 135.00% |
| Change in Net Operating Assets | 23.28% | 39.91% | -190.99% | -154.99% | 36.66% |
| Cash from Operations | -2.64% | 16.28% | 19.08% | 62.41% | 151.80% |
| Capital Expenditure | -14.57% | -7.53% | -8.67% | -13.16% | -36.94% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 74.53% | 74.53% | 74.53% | 73.13% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 150.51% | 143.15% | -419.54% | -2,324.24% | -2,643.78% |
| Cash from Investing | 79.33% | 80.75% | 64.80% | 64.39% | -1,991.82% |
| Total Debt Issued | -98.12% | -97.82% | -98.39% | -30.19% | -- |
| Total Debt Repaid | 97.42% | 97.41% | 78.30% | -273.95% | -14,273.04% |
| Issuance of Common Stock | -- | -- | -74.37% | -56.80% | 67.13% |
| Repurchase of Common Stock | -31.75% | -44.30% | 35.91% | -55.05% | -31.31% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 96.11% | 96.75% | 94.60% | 22.73% | -6,479.48% |
| Cash from Financing | -118.03% | -117.83% | -119.42% | -96.04% | 1,117.28% |
| Foreign Exchange rate Adjustments | 106.33% | 32.62% | -1,568.00% | -355.81% | -125.71% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -174.86% | 161.96% | -169.29% | 355.25% | 515.17% |